Genetics of type 1A (immune mediated) diabetes

Journal of Autoimmunity

Volumn 21, Issue 2, 2003, Pages 93-98

  Melanitou, Evie ^a   Fain, Pam ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; AUTOSOMAL RECESSIVE DISORDER; BIRTH; DISEASE MODEL; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC RISK; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOGENIC DISORDER; MONOZYGOTIC TWINS; MULTIFACTORIAL INHERITANCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYNDROME; X CHROMOSOME LINKAGE;

EID: 0041519032     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-8411(03)00097-0     Document Type: Short Survey

References (46)

1. Bach J.F. Etiology and pathogenesis of human insulin-dependent diabetes mellitus. Volpe R. Contemporary endocrinology: autoimmune endocrinopathies. 1999;293-307 Humana Press Inc, Totowa.
2. Bell G.I., Horita S., Karam J.H. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 33:1984;176-183.
3. Perheentupa J. APS-I/APECED: The clinical disease and therapy. Eisenbarth G.S. Autoimmune polyendocrine syndromes. 31:2002;295-320 W.B. Saunders Company, Philadelphia.
4. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 27:2001;18-20.
5. Hornum L., Romer J., Markholst H. The diabetes-prone BB rat carries a frameshift mutation in Ian4, a positional candidate of Iddm1. Diabetes. 51:2002;1972-1979.
6. MacMurray A.J., Moralejo D.H., Kwitek A.E., Rutledge E.A., Van Yserloo B., Gohlke P., et al. Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene. Genome Res. 12:2002;1029-1039.
7. Yokoi N., Komeda K., Wang H.Y., Yano H., Kitada K., Saitoh Y., et al. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat Genet. 31:2002;391-394.
8. Wucherpfennig K.W., Eisenbarth G.S. Type 1 diabetes. Nat Immunol. 2:2001;1-3.
9. Moriyama H., Wen L., Abiru N., Liu E., Yu L., Miao D., et al. Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide. Proc Natl Acad Sci U S A. 99:2002;5539-5544.
10. Ramsey C., Winqvist O., Puhakka L., Halonen M., Moro A., Kampe O., et al. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet. 11:2002;397-409.
11. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins S, Turley SJ et al. Projection of an immunological self-shadow within the thymus by the Aire protein. Science 2002.
12. Fain P.R., Eisenbarth G.S. Type 1 diabetes, autoimmunity, and the MHC. Lowe W.L. Genetics of diabetes mellitus. 2000;43-64 Kluwer Academic Publishers, Boston/Dordrecht/London.
13. Pugliese A., Brown D., Garza D., Zeller M., Redondo M.J., Eisenbarth G.S., et al. Self-antigen presenting cells expressing islet cell molecules in human thymus and peripheral lymphoid organs: phenotypic characterization and implications for immunological tolerance and type 1 diabetes. J Clin Invest. 107:2001;555-564.
14. Chentoufi A.A., Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes. 51:2002;1383-1390.
15. Hanahan D. Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. Curr Opin Immunol. 10:1998;656-662.
16. Schubert L.A., Jeffery E., Zhang Y., Ramsdell F., Ziegler S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem. 276:2001;37672-37679.
17. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 27:2001;68-73.
18. Ellerman K.E., Like A.A. Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats. Diabetologia. 43:2000;890-898.
19. Todd J.A., Wicker L.S. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity. 15:2001;387-395.
20. Robles DT, Eisenbarth GS, Dailey NJM, Peterson LB, Wicker LS. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice. Diabetes 2002. In Press.
21. Brook F.A., Evans E.P., Lord C.J., Lyons P.A., Rainbow D.B., Howlett S.K., et al. The derivation of highly germline-competent embryonic stem cells containing NOD-derived genome. Diabetes. 52:2003;205-208.
22. Atkinson M.A., Eisenbarth G.S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 358:2001;221-229.
23. Kaprio J., Tuomilehto J., Koskenvuo M., Romanov K., Reunanen A., Eriksson J., et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 35:1992;1060-1067.
24. Kyvik K.O., Green A., Beck-Nielsen H. [The most recent part of the Danish Twin Registry. Establishment and analysis of zygote specific twinning rates]. Ugeskr Laeger. 158:1996;3456-3460.
25. Lorenzen T., Pociot F., Hougaard P., Nerup J. Long-term risk of IDDM in first-degree relatives of patients with IDDM. Diabetologia. 37:1994;321-327.
26. Redondo M.J., Yu L., Hawa M., Mackenzie T., Pyke D.A., Eisenbarth G.S., et al. Heterogenity of type 1 diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 44:2001;354-362.
27. Gale E.A., Bingley P.J., Eisenbarth G.S., Redondo M.J., Kyvik K.O., Petersen J.S. Reanalysis of twin studies suggests that diabetes is mainly genetic. Br Med J. 323:2001;997A.
28. Srikanta S., Ganda O.P., Jackson R.A., Gleason R.E., Kaldany A., Garovoy M.R., et al. Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med. 99:1983;320-326.
29. Devendra D., Eisenbarth G.S. 17 Immunologic endocrine disorders. J Allergy Clin Immunol. 111:2003;624-636.
30. Vogel A., Strassburg C.P., Obermayer-Straub P., Brabant G., Manns M.P. The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components. J Mol Med. 80:2002;201-211.
31. Yamamoto A.M., Deschamps I., Garchon H.J., Roussely H., Moreau N., Beaurain G., et al. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. J Autoimmun. 11:1998;643-650.
32. Lee K.H., Wucherpfennig K.W., Wiley D.C. Structure of a human insulin peptide/HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol. 2:2001;501-507.
33. Langholz B., Tuomilehto-Wolf E., Thomas D., Pitkaniemi J., Tuomilehto J. Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: I. Allele effects at A, B, and DR loci. DiMe Study Group. Childhood Diabetes in Finland. Genet Epidemiol. 12:1995;441-453.
34. Robles D.T., Eisenbarth G.S., Wang T., Erlich H.A., Bugawan T.L., Babu S.R., et al. Millennium award recipient contribution. Identification of children with early onset and high incidence of anti-islet autoantibodies. Clin Immunol. 102:2002;217-224.
35. Lesage S., Zouali H., Cezard J.P., Colombel J.F., Belaiche J., Almer S., et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 70:2002;845-857.
36. Pugliese A., Miceli D. The insulin gene in diabetes. Diabetes Metab Res Rev. 18:2002;13-25.
37. Moriyama H., Paronen J., Liu E., Abiru N., Melanitou E., Babu S., et al. Testing the hypothesis that the insulin 1 gene is essential for diabetogenesis and knockout of insulin 2 gene accelerates diabetes in NOD mice. Diabetes Metabol Res Rev. 18:2002;S26.
38. Dubois-Lafforgue D., Mogenet L., Thebault K., Jami J., Krief P., Boitard C. Proinsulin 2 knockout NOD mice: a model for genetic variation of insulin gene expression in type 1 diabetes. Diabetes. 51:(Suppl 3):2002;S489-S493.
39. Cox N.J., Wapelhorst B., Morrison V.A., Johnson L., Pinchuk L., Spielman R.S., et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet. 69:2001;820-830.
40. McCormack R.M., Maxwell A.P., Carson D., Patterson C.C., Bingham A., Savage D.A. Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population. Genes Immun. 2:2001;233-235.
41. Perez D.N., Bilbao J.R., Nistico L., Buzzetti R., Larsen Z.M., Pociot F., et al. No evidence of association of chromosome 2q with Type I diabetes in the Basque population. Diabetologia. 42:1999;119-120.
42. Verge C.F., Vardi P., Babu S., Bao F., Erlich H.A., Bugawan T., et al. Evidence for oligogenic inheritance of type 1A diabetes in a large Bedouin Arab family. J Clin Invest. 102:1998;1569-1575.
43. Rewers M., Bugawan T.L., Norris J.M., Blair A., Beaty B., Hoffman M., et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia. 39:1996;807-812.
44. Bao F., Yu L., Babu S., Wang T., Hoffenberg E.J., Rewers M., et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease associated transglutaminase autoantibodies. J Autoimmun. 13:1999;143-148.
45. Park Y., Sanjeevi C.B., Gottlieb P., Yu L., Babu S., Rewers M., et al. HLA genotypes (class II, MIC-A, D6S273): Additional association of intra-MHC genes with Addison's disease risk. Tissue Antigens. 60:2002;155-163.
46. Myhre A.G., Undlien D.E., Lovas K., Uhlving S., Nedrebo B.G., Kristian J.F., et al. Autoimmune adrenocortical failure in Norway: Autoantibodies and HLA class II associations related to clinical features. J Clin Endocrinol Metab. 87:2002;618-623.